Salvianolate reduces neuronal apoptosis by suppressing OGD-induced microglial activation
Pengwei Luan1, Xinyue Ding2, Jiazhen Xu2
1The Research Center of Chiral Drugs, Innovation Research Institute of Traditional, Chinese Medicine (IRI), Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Salvianolate reduces microglial inflammation and oxidative stress, protecting neurons from oxygen-glucose deprivation (OGD) injury. This antioxidant compound inhibits the pro-inflammatory phenotype, offering neuroprotection.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Microglia play a crucial role in neuroinflammation.
- Oxygen-glucose deprivation (OGD) induces a pro-inflammatory microglial phenotype.
- This phenotype contributes to neuronal injury.
Purpose of the Study:
- To investigate the mechanism of OGD-induced microglial pro-inflammatory transformation.
- To determine how salvianolate regulates microglial polarization for neuroprotection.
Main Methods:
- Immunofluorescence and Western blot analyzed microglial phenotype and TLR4 signaling.
- RT-qPCR and ELISA measured inflammatory factor levels.
- Flow cytometry and Western blot assessed salvianolate's protective effects on neuronal injury.
Main Results:
- OGD activated TLR4 signaling and microglial inflammation, triggering neuronal caspase-3.
- Salvianolate reduced reactive oxygen species (ROS) and modulated antioxidant enzymes (SOD, CAT, GSH-px).
- Salvianolate inhibited TLR4 signaling, suppressed microglial pro-inflammatory phenotype, and decreased IL-6 and TNF-α expression, reversing OGD-induced neuronal damage.
Conclusions:
- Salvianolate acts as an antioxidant.
- It inhibits the pro-inflammatory phenotype of microglia.
- This action decreases ROS and provides neuroprotection against OGD-induced injury.
More Related Videos
10:50Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
